Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials

Conventional synthetic disease-modifying anti-rheumatic drugs, including methotrexate, may not be tolerated by all patients with rheumatoid arthritis (RA), and limited international data for etanercept (ETN) monotherapy are available. The aim of this review was to summarize the clinical program for...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Kawai, Shinichi, Sugiyama, Naonobu, Yuasa, Hirotoshi, Yamashita, Noriaki, Sugiyama, Noriko, Wagerle, Lorin Craig, Vlahos, Bonnie, Wajdula, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445012/
https://www.ncbi.nlm.nih.gov/pubmed/24842477
http://dx.doi.org/10.3109/14397595.2014.914014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445012/
https://www.ncbi.nlm.nih.gov/pubmed/24842477
http://dx.doi.org/10.3109/14397595.2014.914014

Ejemplares similares